Summary
46 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 14 years in a row.
- Revenue grew by 12% a year over the last 3 years.
What to watch
- The company made a loss over the last 12 months.
- Earnings per share fell by 25% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- Repaying its net debt would take 3.6 years of operating profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to grow by 8.6%. Earnings per share fell by 25% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $6.03M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 6.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 2.18%
- Raised in a row
- 14 years
You receive $1.83 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 10
- Hold 3
- Sell 0
Today's price within the analysts' price targets
The average target of $90 is 7.1% above today's price. 77% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Net Patient Revenues 83%
- Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues 17%
By region
The company reports no revenue by region.
Net Patient Revenues brings in 83% of revenue. Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues grew fastest, by 20% a year.
Segments in detail